Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Consolidated Net Profit

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹9.49 Cr₹15 Cr₹15 Cr₹1,212,944 Cr₹13 Cr

What is the latest Consolidated Net Profit of MEDICAMEN BIOTECH ?

The latest Consolidated Net Profit ratio of MEDICAMEN BIOTECH is ₹9.49 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹9.49 Cr
Mar2024₹15 Cr
Mar2023₹15 Cr
Mar2022₹1,212,944 Cr
Mar2021₹13 Cr

How is Consolidated Net Profit of MEDICAMEN BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹9.49 Cr
-35.54
Mar2024 ₹15 Cr
-1.13
Mar2023 ₹15 Cr
-100.00
Mar2022 ₹1,212,944 Cr
9,125,955.15
Mar2021 ₹13 Cr -

Compare Consolidated Net Profit of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹363.7 Cr -2.7% 7.6% -35.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹457,121.0 Cr 3.2% 12.5% 10.6% Stock Analytics
DIVIS LABORATORIES ₹181,396.0 Cr 2.9% 8.5% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,730.0 Cr 0.3% 5.7% 36.3% Stock Analytics
CIPLA ₹115,241.0 Cr 10.4% 15.9% -5.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,126.0 Cr 4.8% 9% 10.8% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

-2.7%

7.6%

-35.8%

SENSEX

-0.9%

-3.6%

-8.6%


You may also like the below Video Courses